In conclusion, MAGL has a central function in the endocannabinoid system, and MAGL inhibitors are promising therapeutic agents for various disorders, including inflammation, neurodegeneration, metabolic disorders, and even cancers. This evidence concerns the gene MGLL and Other metabolic disease.